Asupplemental long‑form earnings release providing additional operational details and business update for Q4 2025 and the ...

The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press ...

Linerixibat targets pruritus pathobiology in PBC by blocking ileal bile acid reuptake, aiming to lower circulating pruritogenic bile acid–related mediators. GLISTEN demonstrated greater 24-week WI-NRS ...

Zoliflodacin and gepotidacin make oral therapy viable again for urogenital gonorrhea, yet lower pharyngeal efficacy and weak resistance surveillance mean clinicians must adopt cautious, targeted use.

The FDA approved icotrokinra for adults and adolescents aged 12 years and older with moderate to severe plaque psoriasis, Johnson & Johnson announced in a press release. Icotrokinra (Icotyde) is the ...

Aldeyra plans to request a Type A meeting and currently does not intend further clinical trials, asserting rapid-onset activity within minutes versus existing therapies requiring weeks to months.

Melissa Quinn is a senior reporter for CBSNews.com, where she covers U.S. politics, with a focus on the Supreme Court and federal courts. Overseen by the conservative Heritage Foundation, the ...

The integration of Artificial Intelligence (AI) into Citizen Science (CS) is transforming how communities collect, analyze, and share data, offering opportunities for enhanced efficiency, accuracy, ...

Trump revealed that a congressman had faced a "terminal" health condition and said he had only months to live before he personally intervened to help the Republican get surgery.